News Therapeutic Solutions International, Inc. Other OTC

Equities

TSOI

US8833781011

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Therapeutic Solutions International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 30	CI
Therapeutic Solutions International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 17	CI
Therapeutic Solutions International Receives Patent on Commercially Available QuadraMune Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients	Mar. 04	CI
Therapeutic Solutions International, Inc. Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease	Dec. 11	CI
Therapeutic Solutions International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Therapeutic Solutions International, Inc. Announces Successful First Treatment of Patient with FloraStilbene	23-10-20	CI
Res Nova Bio Appoints George Delgado to Scientific Advisory Board	23-10-17	CI
Therapeutic Solutions International, Inc. Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils	23-09-29	CI
Penny Stock Momentum Watchlist (SWISF, IMTL, NIR, TSOI)	23-09-28	AQ
Therapeutic Solutions International Appoints Navneet Boddu to Scientific Advisory Board	23-09-18	CI
Exploring Four Penny Stocks With Recent Headlines (ATVK, ABML, TSOI, IQST)	23-09-12	AQ
Therapeutic Solutions International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Therapeutic Solutions International, Inc. Announces FlorStilbene?? Demonstrates Synergy with Conventional Chemotherapy and Immunotherapy in Reducing Triple Negative Breast Cancer	23-08-21	CI
Allogen Biologics Inc. Successfully Manufactures JadiCell	23-08-16	CI
Friday's OTC Noteworthy News Watchlist (EPAZ, TSOI, DPLS, SHMN)	23-08-04	AQ
Therapeutic Solutions International Subsidiary Res Nova Bio Inc Discovers New Mechanism of Action for Breast Cancer Immunotherapy Adjuvant FloraStilbene?	23-07-18	CI
Therapeutic Solutions International Files for Orphan Drug Designation Use of JadiCell Adult Stem Cells for Treatment of Frontotemporal Dementia	23-07-13	AQ
CapitalGainsReport: Exploring Recent Developments of 4 OTC Stocks (EPAZ, TSOI, GRCU, SIRC)	23-05-26	AQ
Therapeutic Solutions International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16	CI
CapitalGainsReport: Exploring Four Stocks Under a Penny Poised to Pop (HBRM, TSOI, CNNA, AITX)	23-05-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Therapeutic Solutions International, Inc. Other OTC

Equities

TSOI

US8833781011

Summary

Filters